252 related articles for article (PubMed ID: 18266236)
21. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of thiopurine metabolites in predicting azathioprine resistance in pediatric IBD patients.
Nguyen TV; Nguyen TM; Lachaux A; Boulieu R
J Clin Pharmacol; 2013 Sep; 53(9):900-8. PubMed ID: 23856979
[TBL] [Abstract][Full Text] [Related]
23. Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
Björnsson ES; Gu J; Kleiner DE; Chalasani N; Hayashi PH; Hoofnagle JH;
J Clin Gastroenterol; 2017 Jan; 51(1):63-69. PubMed ID: 27648552
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
Spencer E; Norris E; Williams C; Dubinsky MC
Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
[TBL] [Abstract][Full Text] [Related]
25. Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease.
Morales A; Salguti S; Miao CL; Lewis JD
Inflamm Bowel Dis; 2007 Apr; 13(4):380-5. PubMed ID: 17206711
[TBL] [Abstract][Full Text] [Related]
26. Hepatotoxicity of 6-mercaptopurine (6-MP) and Azathioprine (AZA) in adult IBD patients.
Shaye OA; Yadegari M; Abreu MT; Poordad F; Simon K; Martin P; Papadakis KA; Ippoliti A; Vasiliauskas E; Tran TT
Am J Gastroenterol; 2007 Nov; 102(11):2488-94. PubMed ID: 17764490
[TBL] [Abstract][Full Text] [Related]
27. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease.
Lamers CB; Griffioen G; van Hogezand RA; Veenendaal RA
Scand J Gastroenterol Suppl; 1999; 230():111-5. PubMed ID: 10499471
[TBL] [Abstract][Full Text] [Related]
28. Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study.
Vos AC; Bakkal N; Minnee RC; Casparie MK; de Jong DJ; Dijkstra G; Stokkers P; van Bodegraven AA; Pierik M; van der Woude CJ; Oldenburg B; Hommes DW;
Inflamm Bowel Dis; 2011 Sep; 17(9):1837-45. PubMed ID: 21830262
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
Tajiri H; Tomomasa T; Yoden A; Konno M; Sasaki M; Maisawa S; Sumazaki R; Shimizu T; Toyoda S; Etani Y; Nakacho M; Ushijima K; Kobayashi A;
Digestion; 2008; 77(3-4):150-4. PubMed ID: 18577852
[TBL] [Abstract][Full Text] [Related]
30. Allergic reactions to 6-mercaptopurine during treatment of inflammatory bowel disease.
Korelitz BI; Zlatanic J; Goel F; Fuller S
J Clin Gastroenterol; 1999 Jun; 28(4):341-4. PubMed ID: 10372932
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
Belaiche J; Desager JP; Horsmans Y; Louis E
Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
[TBL] [Abstract][Full Text] [Related]
32. Split-dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6-MMP metabolism.
Shih DQ; Nguyen M; Zheng L; Ibanez P; Mei L; Kwan LY; Bradford K; Ting C; Targan SR; Vasiliauskas EA
Aliment Pharmacol Ther; 2012 Sep; 36(5):449-58. PubMed ID: 22784257
[TBL] [Abstract][Full Text] [Related]
33. [Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].
Reinisch W; Dejaco C; Knoflach P; Petritsch W; Vogelsang H; Tilg H
Z Gastroenterol; 2004 Sep; 42(9):1033-45; discussion 1046-7. PubMed ID: 15455280
[TBL] [Abstract][Full Text] [Related]
34. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.
Ramakrishna J; Langhans N; Calenda K; Grand RJ; Verhave M
J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):296-302. PubMed ID: 8708884
[TBL] [Abstract][Full Text] [Related]
35. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH
Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102
[TBL] [Abstract][Full Text] [Related]
36. Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease.
Grosen A; Nersting J; Bungum M; Christensen LA; Schmiegelow K; Spanò M; Julsgaard M; Cordelli E; Leter G; Larsen PB; Hvas CL; Kelsen J
J Crohns Colitis; 2019 Jan; 13(1):3-11. PubMed ID: 29917107
[TBL] [Abstract][Full Text] [Related]
37. Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis.
Nguyen TV; Vu DH; Nguyen TM; Lachaux A; Boulieu R
Ther Drug Monit; 2013 Apr; 35(2):251-7. PubMed ID: 23503453
[TBL] [Abstract][Full Text] [Related]
38. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).
Shim L; Eslick GD; Simring AA; Murray H; Weltman MD
J Crohns Colitis; 2011 Jun; 5(3):234-8. PubMed ID: 21575887
[TBL] [Abstract][Full Text] [Related]
39. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease.
Kader HA; Wenner WJ; Telega GW; Maller ES; Baldassano RN
J Clin Gastroenterol; 2000 Jun; 30(4):409-13. PubMed ID: 10875470
[TBL] [Abstract][Full Text] [Related]
40. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study.
Nørgård BM; Magnussen B; Larsen MD; Friedman S
Gut; 2017 Oct; 66(10):1761-1766. PubMed ID: 27456154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]